Literature DB >> 19913842

Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat.

Zuoquan Xie1, Houkai Li, Ke Wang, Jingchao Lin, Qi Wang, Guoping Zhao, Wei Jia, Qinghua Zhang.   

Abstract

Excessive energy intake greatly contributes to the development of nonalcoholic fatty liver disease (NAFLD) in modern society. To better understand the comprehensive mechanisms of NAFLD development, we investigated the metabolic alterations of rats with NAFLD induced by high-fat diet (HFD). Male Wistar rats were fed a HFD or standard chow for control. After 16 weeks, rat serum was collected for biochemical measurement. The rats' livers were resected and subjected to histology inspection and gene expression analysis with complementary DNA microarray and metabolic analysis with gas chromatography-mass spectroscopy. In HFD rats, the serum cholesterol, triglycerides, glucose, and insulin contents were increased; and the total cholesterol and triglycerides in the livers were also significantly increased. Complementary DNA microarray analysis revealed that 130 genes were regulated by HFD. Together with real-time reverse transcriptase polymerase chain reaction, lipid metabolism regulatory members like sterol regulatory element binding factor 1 and stearoyl-coenzyme A desaturase 1 had up-regulation, whereas others like peroxisome proliferator-activated receptor, carnitine palmitoyltransferase 1, and 3-hydroxy-3-methylglutaryl-coenzyme A reductase had repressed expression, in HFD rat livers. Metabolomic analysis showed that tetradecanoic acid, hexadecanoic acid, and oleic acid had elevation and arachidonic acid and eicosapentaenoic acid had decreased content in HFD rat livers. Amino acids including glycine, alanine, aspartic acid, glutamic acid, and proline contents were decreased. The integrative results from transcriptomic and metabolomic studies revealed that, in HFD rat livers, fatty acid utilization through beta-oxidation was inhibited and lipogenesis was enhanced. These observations facilitated our understanding of the pathways involved in the development of NAFLD induced by HFD. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913842     DOI: 10.1016/j.metabol.2009.08.022

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  30 in total

Review 1.  Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

Authors:  Munechika Enjoji; Makoto Nakamuta
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

2.  Dietary regulation of catabolic disposal of 4-hydroxynonenal analogs in rat liver.

Authors:  Qingling Li; Kristyen Tomcik; Shenghui Zhang; Michelle A Puchowicz; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2012-01-04       Impact factor: 7.376

3.  Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats.

Authors:  Li-fang Zhang; Ling-sheng Liu; Xiao-man Chu; Hao Xie; Li-juan Cao; Cen Guo; Ji-ye A; Bei Cao; Meng-jie Li; Guang-ji Wang; Hai-ping Hao
Journal:  Acta Pharmacol Sin       Date:  2014-01-20       Impact factor: 6.150

4.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Authors:  Jonathan Barr; Mercedes Vázquez-Chantada; Cristina Alonso; Miriam Pérez-Cormenzana; Rebeca Mayo; Asier Galán; Juan Caballería; Antonio Martín-Duce; Albert Tran; Conrad Wagner; Zigmund Luka; Shelly C Lu; Azucena Castro; Yannick Le Marchand-Brustel; M Luz Martínez-Chantar; Nicolas Veyrie; Karine Clément; Joan Tordjman; Philippe Gual; José M Mato
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

5.  Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis.

Authors:  Rita S Strakovsky; Huan Wang; Nicki J Engeseth; Jodi A Flaws; William G Helferich; Yuan-Xiang Pan; Stéphane Lezmi
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-05       Impact factor: 4.219

6.  Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet.

Authors:  Alesia Walker; Barbara Pfitzner; Susanne Neschen; Melanie Kahle; Mourad Harir; Marianna Lucio; Franco Moritz; Dimitrios Tziotis; Michael Witting; Michael Rothballer; Marion Engel; Michael Schmid; David Endesfelder; Martin Klingenspor; Thomas Rattei; Wolfgang Zu Castell; Martin Hrabé de Angelis; Anton Hartmann; Philippe Schmitt-Kopplin
Journal:  ISME J       Date:  2014-06-06       Impact factor: 10.302

7.  R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles.

Authors:  Liam A Finlay; Alex J Michels; Judy A Butler; Eric J Smith; Jeffrey S Monette; Régis F Moreau; Shay Kate Petersen; Balz Frei; Tory M Hagen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-02       Impact factor: 3.619

Review 8.  Maternal obesity and fetal metabolic programming: a fertile epigenetic soil.

Authors:  Margaret J R Heerwagen; Melissa R Miller; Linda A Barbour; Jacob E Friedman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-07-14       Impact factor: 3.619

9.  Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling.

Authors:  Laura Markey; Andrew Hooper; Laverne C Melon; Samantha Baglot; Matthew N Hill; Jamie Maguire; Carol A Kumamoto
Journal:  Psychoneuroendocrinology       Date:  2020-07-24       Impact factor: 4.905

10.  Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).

Authors:  Mary K Wojczynski; Laurence D Parnell; Toni I Pollin; Chao Q Lai; Mary F Feitosa; Jeff R O'Connell; Alexis C Frazier-Wood; Quince Gibson; Stella Aslibekyan; Kathy A Ryan; Michael A Province; Hemant K Tiwari; Jose M Ordovas; Alan R Shuldiner; Donna K Arnett; Ingrid B Borecki
Journal:  Metabolism       Date:  2015-07-03       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.